Vyvyan Campbell, Director at PetLife Pharmaceuticals, Inc. (PTLF), bought 305,000 shares at $0.40 ($123K) on 2018-02-28, disclosed to the SEC on 2018-03-20.
Open-market purchase of $123k PTLF by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |